
Sign up to save your podcasts
Or


This week: how accurate is clinical gestalt (https://www.ncbi.nlm.nih.gov/pubmed/31208974), canagliflozin and renal outcomes in high risk patients (https://www.ncbi.nlm.nih.gov/pubmed/30990260) and whether oral immunotherapy for peanut allergy is safe and effective (https://www.ncbi.nlm.nih.gov/pubmed/31030987).
By Mark Ebell4.7
9292 ratings
This week: how accurate is clinical gestalt (https://www.ncbi.nlm.nih.gov/pubmed/31208974), canagliflozin and renal outcomes in high risk patients (https://www.ncbi.nlm.nih.gov/pubmed/30990260) and whether oral immunotherapy for peanut allergy is safe and effective (https://www.ncbi.nlm.nih.gov/pubmed/31030987).

137 Listeners

700 Listeners

497 Listeners

288 Listeners

283 Listeners

262 Listeners

3,342 Listeners

1,153 Listeners

194 Listeners

86 Listeners

513 Listeners

365 Listeners

248 Listeners

370 Listeners

314 Listeners